• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Epicentrx Adapt-001 Oral Presentation: Advanced Tgf? Trap At Asco 2024

    PR NEWSWIRE

    EpicentRx Receives Fast Track Designation from U.S. FDA for Lead Asset, RRx-001

    PR NEWSWIRE

    Promising Safety and Efficacy Signals from a Small Phase 1 Pilot Study (PRIMETIME) with RRx-001 + Opdivo in Traditionally Checkpoint Inhibitor Non-Responsive Tumors

    PR NEWSWIRE

    EpicentRx to Present for PII Trial to Assess Efficacy of RRx-001 vs. regorafenib

    PR NEWSWIRE

    EpicentRx Publishes Phase 2 Results for RRx-001 as an Anti-Mucositis Agent

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.